This website and its contents are Copyright © 2009-2010 Trilogy Capital Partners, Inc. All rights reserved. All trademarks or registered trademarks are the property of their respective holders. This web site and all content contained within may not be copied or reproduced in whole or in part without the express permission of Trilogy Capital Partners and, if applicable, its Portfolio Clients or Partners. [ top ]
Safe Harbor Statement
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this website contains certain forward-looking statements pertaining to future anticipated projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this website that are not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These statements by their nature are estimates of future results only and involve substantial risks and uncertainties. There can be no assurance that actual results will not differ materially from expectations.
[ top ]
This website, www.trilogy-capital.com, is provided by Trilogy Capital Partners, Inc. ("Trilogy") to provide readers with information on publicly traded companies which have retained Trilogy provide investor relations services. Trilogy receives compensation for those services from the company, which compensation consists of cash and/or securities of the company. In addition, Trilogy from time to time receives additional compensation for these services from shareholders of the company in the form of warrants at prices generally in excess of market prices at the date of issuance of the warrants.
Factual information is obtained from public filings and other sources deemed to be reliable; however, Trilogy takes no responsibility for verifying the accuracy of such information and makes no representation that such information is accurate or complete. Certain of the statements in this website may be considered forwarded looking statements. Trilogy makes no representation and provides no assurance or guaranty that such forward looking statements will be prove to be accurate. Statements of opinion and belief are those of the authors and/or editors of this website, and are based solely upon the information possessed by such authors and/or editors; no inference should be drawn that such authors or editors have any special or greater knowledge about the companies profiled or any particular expertise in the industries or markets in which the profiled companies compete. The reader should verify all claims and complete his own due diligence before investing in any securities of profiled companies. Neither Trilogy nor anyone involved in the publication of this website is a registered investment adviser or broker/dealer. Trilogy makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. An investor in such securities should be prepared and able to bear a loss of his or her entire investment. Nothing in this website should be construed as an offer or solicitation to buy or sell any securities of any profiled company. Further, Trilogy and its employees and affiliates may own, or may purchase and sell, securities of the companies profiled. Trilogy undertakes no obligation to inform readers about the ownership or trading activities of it or its employees or affiliates in the securities of the profiled companies. Trilogy from time to time enters into agreements to provide purchase securities of publicly traded companies to provide financing to these companies. [ top ]
17B Compensation Disclosures
Bohai Pharmaceuticals Group
Trilogy Capital Partners, Inc. (“Trilogy”) has been engaged by Bohai Pharmaceuticals Group, Inc. ("BOPH") to provide investor relations services for compensation of a monthly retainer in the amount of $12,500. Trilogy Capital Partners owns 31,250 shares of the Common Stock of BOPH. In addition, Alfonso J. Cervantes, the principal of Trilogy, beneficially owns 90,000 shares of the Common stock of BOPH through La Mancha Capital Group, LLC, a limited liability company and is a non-managing member of Regeneration Capital Group, LLC, which owns 541,875 shares of the Common Stock of BOPH. [ top ]